15801997

Source:http://linkedlifedata.com/resource/pubmed/id/15801997

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013557, umls-concept:C0032285, umls-concept:C0085565, umls-concept:C0086583, umls-concept:C0087111
pubmed:issue	2
pubmed:dateCreated	2005-4-1
pubmed:abstractText	To evaluate the resource consumption and outcomes associated with first-line monotherapy for community-acquired pneumonia, focusing specifically on the use of erythromycin, azithromycin, clarithromycin, and levofloxacin. Study design: Retrospective managed care database analysis.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0351014
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Azithromycin, http://linkedlifedata.com/resource/pubmed/chemical/Clarithromycin, http://linkedlifedata.com/resource/pubmed/chemical/Erythromycin, http://linkedlifedata.com/resource/pubmed/chemical/Ofloxacin
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0300-7995
pubmed:author	pubmed-author:ArmstrongEdward PEP, pubmed-author:MaloneDaniel CDC, pubmed-author:RamachandranSulabhaS, pubmed-author:SkrepnekGrant HGH
pubmed:issnType	Print
pubmed:volume	21
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	261-70
pubmed:dateRevised	2009-11-3
pubmed:meshHeading	pubmed-meshheading:15801997-Adolescent, pubmed-meshheading:15801997-Adult, pubmed-meshheading:15801997-Anti-Bacterial Agents, pubmed-meshheading:15801997-Azithromycin, pubmed-meshheading:15801997-Clarithromycin, pubmed-meshheading:15801997-Community-Acquired Infections, pubmed-meshheading:15801997-Databases as Topic, pubmed-meshheading:15801997-Erythromycin, pubmed-meshheading:15801997-Female, pubmed-meshheading:15801997-Health Care Costs, pubmed-meshheading:15801997-Humans, pubmed-meshheading:15801997-Male, pubmed-meshheading:15801997-Managed Care Programs, pubmed-meshheading:15801997-Middle Aged, pubmed-meshheading:15801997-Models, Econometric, pubmed-meshheading:15801997-Ofloxacin, pubmed-meshheading:15801997-Pneumonia, Bacterial, pubmed-meshheading:15801997-Retrospective Studies, pubmed-meshheading:15801997-Risk Assessment, pubmed-meshheading:15801997-Treatment Outcome
pubmed:year	2005
pubmed:articleTitle	An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
pubmed:affiliation	Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, College of Pharmacy, Tucson, AZ 85721, USA. skrepnek@pharmacy.arizona.edu
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't